| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4401552
[patent_doc_number] => 06171591
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Recombinant nodavirus compositions and methods'
[patent_app_type] => 1
[patent_app_number] => 8/986659
[patent_app_country] => US
[patent_app_date] => 1997-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12331
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/171/06171591.pdf
[firstpage_image] =>[orig_patent_app_number] => 986659
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/986659 | Recombinant nodavirus compositions and methods | Dec 7, 1997 | Issued |
| 08/952694 | IGG/IGM RATIO FOR DETERMINING EFFECTIVENESS OF INTERFERON THERAPY IN INDIVIDUALS WITH HCV INFECTIONS | Dec 4, 1997 | Abandoned |
| 08/978291 | HLA-RESTRICTED HEPATITIS B VIRUS CTL EPITOPES | Nov 24, 1997 | Abandoned |
Array
(
[id] => 4253688
[patent_doc_number] => 06203827
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Composition containing readily absorbable calcium and process for producing the same'
[patent_app_type] => 1
[patent_app_number] => 8/952738
[patent_app_country] => US
[patent_app_date] => 1997-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4065
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/203/06203827.pdf
[firstpage_image] =>[orig_patent_app_number] => 952738
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/952738 | Composition containing readily absorbable calcium and process for producing the same | Nov 24, 1997 | Issued |
Array
(
[id] => 1564980
[patent_doc_number] => 06376170
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Ligand capture-directed selection of antibody'
[patent_app_type] => B1
[patent_app_number] => 08/972564
[patent_app_country] => US
[patent_app_date] => 1997-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 16837
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376170.pdf
[firstpage_image] =>[orig_patent_app_number] => 08972564
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/972564 | Ligand capture-directed selection of antibody | Nov 17, 1997 | Issued |
Array
(
[id] => 3995019
[patent_doc_number] => 05922553
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'Method of detecting protein by immuno RNA'
[patent_app_type] => 1
[patent_app_number] => 8/972225
[patent_app_country] => US
[patent_app_date] => 1997-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3605
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922553.pdf
[firstpage_image] =>[orig_patent_app_number] => 972225
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/972225 | Method of detecting protein by immuno RNA | Nov 16, 1997 | Issued |
| 08/913080 | METHOD FOR THE DIAGNOSIS OF INFECTIONS | Nov 9, 1997 | Abandoned |
Array
(
[id] => 4144294
[patent_doc_number] => 06063583
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'Cyclic amp response element binding protein (CREB)-CREB binding protein complex'
[patent_app_type] => 1
[patent_app_number] => 8/961739
[patent_app_country] => US
[patent_app_date] => 1997-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16240
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/063/06063583.pdf
[firstpage_image] =>[orig_patent_app_number] => 961739
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/961739 | Cyclic amp response element binding protein (CREB)-CREB binding protein complex | Oct 30, 1997 | Issued |
| 08/860847 | METHODS FOR INHIBITING THE TRANSCRIPTION-ENHANCING ACTIVITY OF THE X PROTEIN OF HEPATITIS B VIRUS | Oct 15, 1997 | Abandoned |
Array
(
[id] => 3949201
[patent_doc_number] => 05998584
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome'
[patent_app_type] => 1
[patent_app_number] => 8/949017
[patent_app_country] => US
[patent_app_date] => 1997-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15391
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998584.pdf
[firstpage_image] =>[orig_patent_app_number] => 949017
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/949017 | Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome | Oct 9, 1997 | Issued |
Array
(
[id] => 1477793
[patent_doc_number] => 06451592
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis'
[patent_app_type] => B1
[patent_app_number] => 08/944465
[patent_app_country] => US
[patent_app_date] => 1997-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 68
[patent_no_of_words] => 73701
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451592.pdf
[firstpage_image] =>[orig_patent_app_number] => 08944465
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/944465 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Oct 5, 1997 | Issued |
Array
(
[id] => 4308495
[patent_doc_number] => 06316209
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Methods for diabetes susceptibility assessment in asymptomatic patients'
[patent_app_type] => 1
[patent_app_number] => 8/937955
[patent_app_country] => US
[patent_app_date] => 1997-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5792
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316209.pdf
[firstpage_image] =>[orig_patent_app_number] => 937955
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/937955 | Methods for diabetes susceptibility assessment in asymptomatic patients | Sep 24, 1997 | Issued |
| 08/914403 | PEPTIDE LIBRARY AND SCREENING SYSTEMS | Aug 18, 1997 | Abandoned |
Array
(
[id] => 1535756
[patent_doc_number] => 06337180
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Peptide reagent enabling a primary Epstein-Barr virus infection to be detected by testing for the corresponding antibodies, and method for using this reagent'
[patent_app_type] => B1
[patent_app_number] => 08/860089
[patent_app_country] => US
[patent_app_date] => 1997-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3248
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337180.pdf
[firstpage_image] =>[orig_patent_app_number] => 08860089
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/860089 | Peptide reagent enabling a primary Epstein-Barr virus infection to be detected by testing for the corresponding antibodies, and method for using this reagent | Aug 14, 1997 | Issued |
Array
(
[id] => 1331202
[patent_doc_number] => 06596476
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Hepatitis C assay'
[patent_app_type] => B1
[patent_app_number] => 08/905054
[patent_app_country] => US
[patent_app_date] => 1997-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14739
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596476.pdf
[firstpage_image] =>[orig_patent_app_number] => 08905054
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/905054 | Hepatitis C assay | Jul 31, 1997 | Issued |
Array
(
[id] => 3994920
[patent_doc_number] => 05922545
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'In vitro peptide and antibody display libraries'
[patent_app_type] => 1
[patent_app_number] => 8/902623
[patent_app_country] => US
[patent_app_date] => 1997-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 33292
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922545.pdf
[firstpage_image] =>[orig_patent_app_number] => 902623
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/902623 | In vitro peptide and antibody display libraries | Jul 28, 1997 | Issued |
Array
(
[id] => 1599715
[patent_doc_number] => 06475717
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-05
[patent_title] => 'Method for detecting and determining mediators'
[patent_app_type] => B1
[patent_app_number] => 08/900576
[patent_app_country] => US
[patent_app_date] => 1997-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7584
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/475/06475717.pdf
[firstpage_image] =>[orig_patent_app_number] => 08900576
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/900576 | Method for detecting and determining mediators | Jul 24, 1997 | Issued |
Array
(
[id] => 4264651
[patent_doc_number] => 06306579
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Recombinant antigen from the NS3 region of the hepatitis C virus'
[patent_app_type] => 1
[patent_app_number] => 8/892704
[patent_app_country] => US
[patent_app_date] => 1997-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6870
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/306/06306579.pdf
[firstpage_image] =>[orig_patent_app_number] => 892704
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/892704 | Recombinant antigen from the NS3 region of the hepatitis C virus | Jul 14, 1997 | Issued |
Array
(
[id] => 4125894
[patent_doc_number] => 06146614
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Method for determining lymphocyte distribution and trafficking in mammals using imaging'
[patent_app_type] => 1
[patent_app_number] => 8/886578
[patent_app_country] => US
[patent_app_date] => 1997-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7646
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/146/06146614.pdf
[firstpage_image] =>[orig_patent_app_number] => 886578
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/886578 | Method for determining lymphocyte distribution and trafficking in mammals using imaging | Jun 30, 1997 | Issued |
Array
(
[id] => 4296850
[patent_doc_number] => 06251407
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence'
[patent_app_type] => 1
[patent_app_number] => 8/820943
[patent_app_country] => US
[patent_app_date] => 1997-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5655
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251407.pdf
[firstpage_image] =>[orig_patent_app_number] => 820943
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/820943 | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence | Jun 5, 1997 | Issued |